Allelic variation at the 8q23.3 colorectal cancer risk locus functions as a cis-acting regulator of EIF3H.
about
Identification of genes expressed by immune cells of the colon that are regulated by colorectal cancer-associated variantsFunctional annotation of putative regulatory elements at cancer susceptibility LociClassifying leukemia types with chromatin conformation data.Systematic search for enhancer elements and somatic allelic imbalance at seven low-penetrance colorectal cancer predisposition loci.Association of Caucasian-identified variants with colorectal cancer risk in Singapore Chinese.Genome-wide identification of expression quantitative trait loci (eQTLs) in human heartEssential gene profiles in breast, pancreatic, and ovarian cancer cells.Polymorphisms in the ERCC5 gene and risk of esophageal squamous cell carcinoma (ESCC) in Eastern Chinese populations.Analyzing large-scale samples confirms the association between rs16892766 polymorphism and colorectal cancer susceptibility.Fine-mapping of colorectal cancer susceptibility loci at 8q23.3, 16q22.1 and 19q13.11: refinement of association signals and use of in silico analysis to suggest functional variation and unexpected candidate target genes.Alterations in TCF7L2 expression define its role as a key regulator of glucose metabolism.COGENT (COlorectal cancer GENeTics) revisited.Characterization of gene-environment interactions for colorectal cancer susceptibility loci.Genetic architecture of colorectal cancer.Regulatory variation in a TBX5 enhancer leads to isolated congenital heart disease.Fine-Mapping of Common Genetic Variants Associated with Colorectal Tumor Risk Identified Potential Functional Variants.Spatial Organization of Epigenomes.Clinical relevance of 8q23, 15q13 and 18q21 SNP genotyping to evaluate colorectal cancer riskUrinary bladder cancer susceptibility markers. What do we know about functional mechanisms?Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk.3D genome organization in health and disease: emerging opportunities in cancer translational medicine.Characterization of the colorectal cancer-associated enhancer MYC-335 at 8q24: the role of rs67491583Beyond GWASs: illuminating the dark road from association to functionNext generation sequencing and a new era of medicine.Hotspots of aberrant enhancer activity punctuate the colorectal cancer epigenome.Cooperative genomic alteration network reveals molecular classification across 12 major cancer types.Diagnostic cancer genome sequencing and the contribution of germline variants.Human genetic variation within neural crest enhancers: molecular and phenotypic implications.Genome variation and personalized cancer medicine.Dissecting the causal genetic mechanisms of coronary heart disease.Architecture of inherited susceptibility to colorectal cancer: a voyage of discovery.Phytohormone mediation of interactions between herbivores and plant pathogens.Comprehensive evaluation of the impact of 14 genetic variants on colorectal cancer phenotype and risk.The association of low penetrance genetic risk modifiers with colorectal cancer in lynch syndrome patients: a systematic review and meta-analysis.Altered TERT promoter and other genomic regulatory elements: occurrence and impact.Association of 8q23-24 region (8q23.3 loci and 8q24.21 loci) with susceptibility to colorectal cancer: a systematic and updated meta-analysis.The non-coding variant rs1800734 enhances DCLK3 expression through long-range interaction and promotes colorectal cancer progressionTranscriptional enhancers in development and disease.Investigation of the effects of DNA repair gene polymorphisms on the risk of colorectal cancer.Exome resequencing identifies potential tumor-suppressor genes that predispose to colorectal cancer.
P2860
Q24338843-FB7BDB26-5E87-4D64-88AE-AD050C83BD74Q30367526-AB4F2032-7E65-4CF3-BE4A-3A62E59777BEQ30835184-B76907BD-2D82-4A1B-81E1-5107B8B0D105Q30999822-1EDBBE5E-F69D-4D05-9EA7-92C3E07E7BBAQ31082944-9E53CB83-E4FC-46AF-835B-318984520CBFQ33638413-4BB02177-5CA0-4B12-A895-94E365DF9E94Q34268870-6394002E-39A2-4C9F-B382-71BE5E85B036Q34358540-24EDC701-CEA0-451D-898D-484305D1E9FDQ34997037-48ECF140-D68B-4731-8879-71DBAD582B7AQ35056061-3109B31C-CCB0-42C4-8D46-E98D34638CA5Q35195941-2D876497-5C7C-4B84-8C60-CAB5665EE1A9Q35714414-F033597B-6B10-4950-8042-EE6E456AFD0BQ36030354-E6CC8FBD-F18E-4154-8E18-E58832820174Q36053127-FB473DDE-D8AA-4972-8581-923FF9AC6945Q36062037-E083AB52-0F1D-4437-A9AD-DAE890B9F0A4Q36068167-926A4BBD-183F-4A84-8EA3-0173FE1F8885Q36491208-52607529-7CE1-494C-A2E0-C73B7DE34994Q36695815-BEF44405-2D82-416B-A7E6-BC03164DB1F3Q37007328-F635D73E-86A0-4CD4-A671-9F00290D1082Q37008880-3025A304-103D-4F15-B814-0152D14A50DBQ37025407-C4ADC920-F866-47B4-B54B-2990F590F178Q37163691-4B779D1C-E503-4289-B88D-658ED9B548FFQ37298148-E44EDC09-BA05-4370-A1EC-E7C4ED45C772Q37409165-C96E6E36-D412-4978-B630-2F5843D748BCQ37642474-DD234791-97B0-4F9D-B0FE-3F1F385D58D1Q37649442-62B3D9E8-7430-4DF7-9DFC-64AE51ACA5A4Q38094131-7D9BC48A-94F5-4A6C-9310-373387782A77Q38104719-8C9CE784-A5F6-4FAB-8831-D3AB548E159EQ38113300-601E018C-25FA-4C74-9835-FB196F78B76DQ38195526-713AF469-0373-470F-8D8E-F47921B2474EQ38202510-D5A31FE9-EE09-4C61-9966-4C7922EFC190Q38233658-57050AA8-EF42-47CE-B708-D3AC7B81A228Q38435623-E26C8B44-0E25-4A84-8499-3D9C3B7829F3Q38784192-EB88D5AD-F87D-4AE6-8AA5-E0F4EF29C8C9Q38838144-DABF9879-1A30-483E-8792-1615BF2AE588Q39991558-D9354BC3-AAB5-4668-B3E1-8082AF2AAF78Q40337066-F3F90DA0-A3CB-4B3F-8E84-66418C996BCDQ41901525-57326046-FA87-460B-BFD3-746D1B786E6DQ42266358-D54B5550-AAD6-449C-AD4F-5A194A7570C9Q44434381-57D6CC9B-C07E-4276-BFC2-4C7A80AD65EA
P2860
Allelic variation at the 8q23.3 colorectal cancer risk locus functions as a cis-acting regulator of EIF3H.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Allelic variation at the 8q23. ...... cis-acting regulator of EIF3H.
@ast
Allelic variation at the 8q23. ...... cis-acting regulator of EIF3H.
@en
type
label
Allelic variation at the 8q23. ...... cis-acting regulator of EIF3H.
@ast
Allelic variation at the 8q23. ...... cis-acting regulator of EIF3H.
@en
prefLabel
Allelic variation at the 8q23. ...... cis-acting regulator of EIF3H.
@ast
Allelic variation at the 8q23. ...... cis-acting regulator of EIF3H.
@en
P2093
P2860
P50
P1433
P1476
Allelic variation at the 8q23. ...... cis-acting regulator of EIF3H
@en
P2093
Angela Gavilán
Bianca Olver
Hans Morreau
Jayaram Vijayakrishnan
M Eva Alonso
Mobshra Qureshi
Philip Twiss
Sanni E Jalava
Sari Tuupanen
P2860
P304
P356
10.1371/JOURNAL.PGEN.1001126
P50
P577
2010-09-16T00:00:00Z